The patent protection for Thalidomide expired. Other companies could now manufacture the substance without having to ask Grünenthal for permission.
Source: Chronology of events provided by Beate Kirk, in: Der Conterganfall: eine unvermeidbare Arzneimittelkatastrophe? Dissertation. Greifswald 1998.